5 recruiting, 2 completed. 6 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 6 | Recruiting 5, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Rajesh Narendran: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Imaging Mitochondrial Complex-I in Alcohol Use Disorder [F-18]BCPP-EF, [F-18]FDG - Alcohol Use Disorder (AUD), Healthy Controls Group - Age and Sex-matched | Early Phase 1 | Recruiting | Rajesh Narendran | 100 | 2026-09-30 | 2026-09-17 |
| Imaging Mitochondrial Complex-I in Cocaine Use Disorder: a [F-18]BCPP-EF PET Study [F-18]BCPP-EF - Cocaine Use Disorder, Healthy Controls Group - Age and Sex-matched | Early Phase 1 | Recruiting | Rajesh Narendran | 40 | 2026-09-04 | 2026-09-14 |
| Imaging CRF X NOP Interactions in Alcohol Use Disorder Baseline [C-11]NOP-1A PET scan, Hydrocortisone, Post-hydrocortisone [C-11]NOP-1A PET scan - Alcohol Use Disorder | Early Phase 1 | Recruiting | Rajesh Narendran | 90 | 2026-06-01 | 2026-06-03 |
| [C-11]NPA PET-amphetamine in Cocaine Use Disorders Baseline [C-11]NPA PET Scan, d-amphetamine, Post-amphetamine [C-11]NPA PET Scan - Cocaine Use Disorder | Early Phase 1 | Recruiting | Rajesh Narendran | 30 | 2021-01-31 | 2026-07-06 |
| Imaging CRF X NOP Interactions in CUD Baseline [C-11]NOP-1A PET Scan, Hydrocortisone, Post-hydrocortisone [C-11]NOP-1A PET Scan - Cocaine Use Disorder | Early Phase 1 | Recruiting | Rajesh Narendran | 80 | 2020-12-31 | 2026-07-06 |
| [C-11]NOP-1A and Alcohol Use Disorder [C-11], NOP-1A - Alcohol Use Disorder | Early Phase 1 | Completed | Rajesh Narendran | 54 | 2016-05-27 | 2022-07-11 |
| Characterization of [11C]Flumazenil to Image GABA Transmission in Healthy Adult Subjects and Subjects With Alcohol Dependence [11C]flumazenil, Tiagabine - Alcoholism | Phase 1 | Completed | Rajesh Narendran | 11 | 2011-04-19 | 2017-08-29 |
Alcoholism (4)
BaseLine dental cement (3) · Hydrocortisone (2) · 3-(2'-fluoro-6',7'-dihydrospiro(piperidine-4,4'-thieno(3,2-c)pyran)-1-yl)-2-(2-fluorobenzyl)-N-methylpropanamide (1) · 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) (1) · Dextroamphetamine (1) · Tiagabine (1)
United States (7)
R01DA026472 (2), R01AA025247 (1), R01AA031453 (1), R01AA032487 (1), R61DA062821 (1)